17 April 2024
Appendix 3Y
16 April 2024
Appendix 3Y
15 April 2024
Appendix 3Y
8 April 2024
Medicxi and Starpharma create Petalion Therapeutics to develop novel dendrimer-based treatments
8 April 2024
Investor Webinar Notification – Starpharma x Medicxi Partnership
1 March 2024
S&P DJI Announces March 2024 Quarterly Rebalance
28 February 2024
4D and Interim Report and Half-Year Financial Results
19 February 2024
VivaGel® BV US FDA Appeal Outcome
6 February 2024
Appendix 2A
31 January 2024
Quarterly Activities Report & Appendix 4C
29 January 2024
Viraleze shows antiviral efficacy in COVID-19 patients
29 January 2024
VivaGel® BV sales and distribution agreement – MENA region
19 January 2024
DEP® cabazitaxel data presentation at ASCO GI cancer meeting
12 January 2024
App 3H - Lapsed Performance Rights
12 January 2024
App 3X - Initial Directors Interest
12 January 2024
App 3G - Issuance of Performance Rights to C Maley
12 January 2024
App 3Z - Final Directors Interest Notice J Fairley
21 December 2023
Appendix 2A
19 December 2023
Positive DEP® docetaxel Phase 2 results
8 December 2023
Change in Director's Interest Notice

Investor Relations

For general questions about Starpharma Holdings Limited, please contact us at:

T: +61 3 8532 2700
E: investor.relations@starpharma.com


This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.